Catheter Precision, Inc.
VTAK
$0.4101
$0.02526.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 27.07% | 140.88% | 387.78% | 3,057.14% | 1,552.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.07% | 140.88% | 387.78% | 3,057.14% | 1,552.63% |
| Cost of Revenue | 65.22% | 100.00% | -67.11% | -81.37% | -95.47% |
| Gross Profit | 24.05% | 145.12% | 2,857.14% | 380.27% | 159.51% |
| SG&A Expenses | -50.87% | -53.10% | -60.53% | 5.37% | 79.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -51.39% | -54.51% | -64.56% | -22.70% | 0.24% |
| Operating Income | 52.47% | 55.97% | 66.03% | 24.59% | 1.05% |
| Income Before Tax | 85.03% | 88.27% | 92.20% | -162.72% | -189.23% |
| Income Tax Expenses | -- | -- | -- | -- | -25.00% |
| Earnings from Continuing Operations | 85.03% | 88.27% | 92.20% | -162.69% | -189.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.03% | 88.27% | 92.20% | -162.69% | -189.19% |
| EBIT | 52.47% | 55.97% | 66.03% | 24.59% | 1.05% |
| EBITDA | 55.96% | 60.48% | 73.57% | 38.61% | 11.60% |
| EPS Basic | 95.82% | 96.09% | 97.75% | 27.60% | 68.75% |
| Normalized Basic EPS | 83.24% | 88.03% | 99.33% | 87.74% | 91.68% |
| EPS Diluted | 95.82% | 96.09% | 97.75% | 27.60% | 68.75% |
| Normalized Diluted EPS | 83.24% | 88.03% | 99.33% | 87.74% | 91.68% |
| Average Basic Shares Outstanding | 149.91% | 155.01% | 303.97% | 413.82% | 649.05% |
| Average Diluted Shares Outstanding | 149.91% | 155.01% | 303.97% | 413.82% | 649.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
